Malignant Neoplasms clinical trials

Explore recruiting malignant neoplasms clinical trials.

Recruiting malignant neoplasms studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Malignant Neoplasms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The cardiovascular safety and efficacy of cagrilintide 2.4 mg s.c. in combination with semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) once-weekly in participants with established cardiovascular disease

France, Ireland, Netherlands, Poland, Denmark, Bulgaria +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer: ARIADNE

Sweden, Norway, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Malignant Neoplasms trials by city

Malignant Neoplasms clinical trials

Recruiting malignant neoplasms studies right now

A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (B-NHL)

Neurocognition After Radiotherapy in CNS- and Skull-base Tumors

Maintenance Zanzalintinib With Etoposide After HDCT in GCT

A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Wisconsin Ginseng for Decreasing Cancer Related Fatigue

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer

Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery

Q702 for the Treatment of Patients With Hematologic Malignancies

Also recruiting in Europe

The cardiovascular safety and efficacy of cagrilintide 2.4 mg s.c. in combination with semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) once-weekly in participants with established cardiovascular disease

A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer: ARIADNE

Malignant Neoplasms trials by city

Other conditions